Aging delay: of mice and men
- PMID: 33682799
- PMCID: PMC7975961
- DOI: 10.23750/abm.v92i1.11273
Aging delay: of mice and men
Abstract
The evaluation of the safety of a drug in rodents that may be used as geroprotectors is a challenge of current times. In the paper, we discuss approaches to long-term assays for selection of potent aging delay drugs for humans. Priority is given to methods combining evaluation of carcinogenic safety and life-spanning potential. The use of such methods will be time-efficient and economically feasible.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
References
-
- Vaiserman AM, Lushchak OV, Koliada AV. Anti-aging pharmacology. Promises and pitfalls Ageing Res Rev. 2016;31:9–35. doi: 10.1016/j.arr.2016.08.004. - PubMed
-
- World Report on Ageing and Health. Geneva: WHO; 2015.
MeSH terms
LinkOut - more resources
Full Text Sources
